(Q43714851)

English

Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma

scientific article published on 21 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

liver transplantation

1 reference

based on heuristic

inferred from title

Kiyoshi Hasegawa

8

object named as

Kiyoshi Hasegawa

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sumihito Tamura

5

object named as

Sumihito Tamura

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Yasuhiko Sugawara

2

object named as

Yasuhiko Sugawara

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

6

object named as

Taku Aoki

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Norihiro Kokudo

10

object named as

Norihiro Kokudo

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Yoshihiro Sakamoto

7

object named as

Yoshihiro Sakamoto

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Junichi Shindoh

1

object named as

Junichi Shindoh

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

3

object named as

Rihito Nagata

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Junichi Kaneko

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Tomohiro Tanaka

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Transplant International

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

391-398

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Thrombotic microangiopathy after living-donor liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FTRI.12274

21 January 2018

Identifiers

10.1111/TRI.12274

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43714851&oldid=2102778886"